Portfolio (Quarterly)
Guide ↗
Propel Bio Management, LLC
· CIK 0001969764| # | Ticker | Company | Sector | Shares | Value ↓ | % Port | Chg Shares | Chg % | Period Price ① | Since Period ① |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | PHAT | PHATHOM PHARMACEUTICALS INC | Healthcare | 841,272.0 | $9.4M | 5.90% | +100K | +13.5% | $11.12 | +0.4% |
| 2 | DCTH | DELCATH SYS INC | Healthcare | 979,698.0 | $9.2M | 5.77% | +541K | +123.4% | $9.35 | +16.5% |
| 3 | — | ABEONA THERAPEUTICS INC | — | 1,329,899.0 | $6.0M | 3.79% | +499K | +60.1% | $4.52 | — |
| 4 | — | SAB BIOTHERAPEUTICS INC | — | 1,012,790.0 | $3.9M | 2.45% | +360K | +55.1% | $3.84 | — |
| 5 | — | ZEVRA THERAPEUTICS INC | — | 282,418.0 | $2.6M | 1.66% | +219K | +343.5% | $9.35 | — |
| 6 | KLRS | KALARIS THERAPEUTICS INC | Healthcare | 295,771.0 | $1.7M | 1.08% | +254K | +603.3% | $5.82 | -9.9% |
① Period Price is the implied market price on the last day of the reporting period, calculated as reported value ÷ shares held. It is not the fund's purchase price or cost basis — the fund may have initiated or added to the position at any point during the quarter at a different price. Since Period shows the price change from that quarter-end snapshot to today's last price — it reflects stock movement after the report date, not the fund's actual return.
Sector Allocation
Healthcare
75.4%
Energy
24.6%